Takayasu arteritis is a disease that results in the granulomatous inflammation of large vessel walls. Takayasu arteritis is generally observed in young females during the second or third decades of life. This disease is treated by the revascularization of the affected organs either by surgery or by endovascular interventions. In this study, we present a case where renal autotransplantation was performed on a lady with an autologous saphenous vein graft subsequent to numerous previous endovascular interventions for her solitary kidney due to Takayasu arteritis-induced renal artery stenosis. The patient was prevented from becoming dialysis dependent through this surgical intervention. Renal autotransplantation is the choice of treatment, especially for those in whom endovascular interventions have failed. Patient management must include the partnership of an experienced vascular surgeon, transplant urologist, rheumatologist, nephrologist and radiologist.

Keywords:
Autotransplantation, Renal artery stenosis, Saphenous vein grafts, Solitary kidney, Takayasu disease
1.
Keser G, Direskeneli H, Aksu K: Management of Takayasu arteritis: a systematic review. Rheumatology (Oxford) 2014;53:793-801.
2.
Maritati F, Iannuzzella F, Pavia MP, Pasquali S, Vaglio A: Kidney involvement in medium- and large-vessel vasculitis. J Nephrol 2016;29:495-505.
3.
Park HS, Do YS, Park KB, Kim DK, Choo SW, Shin SW, Cho SK, Hyun D, Choo IW: Long term results of endovascular treatment in renal arterial stenosis from Takayasu arteritis: angioplasty versus stent placement. Eur J Radiol 2013;82:1913-1918.
4.
Saadoun D, Lambert M, Mirault T, Resche-Rigon M, Koskas F, Cluzel P, Mignot C, Schoindre Y, Chiche L, Hatron PY, Emmerich J, Cacoub P: Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation 2012;125:813-819.
5.
Feng R, Wei X, Zhao Z, Bao J, Feng X, Qu L, Lu Q, Jing Z: Aortorenal bypass with autologous saphenous vein in Takayasu arteritis-induced renal artery stenosis. Eur J Vasc Endovasc Surg 2011;42:47-53.
6.
Hardy JD, Eraslan S: Autotransplantation of the kidney for high ureteral injury. J Urol 1963;90:563-574.
7.
Yakupoglu YK, Aki FT, Kordan Y, Ozden E, Tonyali S, Bostanci Y, Vuruskan H, Bilen CY, Sarikaya S: Renal autotransplantation at three academic institutions in Turkey. Urol Int 2016;97:466-472.
8.
Chiche L, Kieffer E, Sabatier J, Colau A, Koskas F, Bahnini A: Renal autotransplantation for vascular disease: late outcome according to etiology. J Vasc Surg 2003;37:353-361.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.